Tech Company Financing Transactions
Crown Bioscience Funding Round
On 5/3/2011, Crown Bioscience raised $28.8 million in Series C funding from OrbiMed, Argonaut Private Equity and CDIB Bioscience.
Transaction Overview
Company Name
Announced On
5/3/2011
Transaction Type
Venture Equity
Amount
$28,800,000
Round
Series C
Investors
OrbiMed (Lead Investor) (Nancy Chang)
Argonaut Private Equity (Anil Khatod)
Proceeds Purpose
The proceeds will be used for expanding services in integrated cancer drug discovery and translational oncology, as well as to fund new initiatives in other therapeutic areas.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
16550 West Bernardo Dr. Building 5 525
San Diego, CA 92127
USA
San Diego, CA 92127
USA
Phone
Website
Email Address
Not Recorded
Overview
CrownBio is at the forefront of oncology research and cancer immunotherapy providing the largest commercial collection of well-characterised patient derived xenograft models.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jean-Pierre Wery
Chief Financial Officer
Eva Ho
Vice President
Leon Hall
Vice President
Henry Li
VP - Operations
Yangzhou Wang
VP - R & D
Yixin Wang
Browse more venture capital transactions:
Prev: 5/2/2011: NoiseToys venture capital transaction
Next: 5/3/2011: Awarepoint venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs